Insider · CIK 0001746251
Scott Dreyer
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC). First filing Mar 10, 2025, latest Mar 5, 2026.
Scott Dreyer files SEC Form 4 as officer at COLL (COLLEGIUM PHARMACEUTICAL, INC). Since Mar 10, 2025, Scott Dreyer has reported 0 open-market buys worth $0 and 8 open-market sells worth $5.0M, the latest filed on Mar 5, 2026.
A track record needs three past buys with six months of prices behind them; Scott Dreyer has 0, so none is measured yet.
The newest scored trade: sold $2.0M of COLL on Mar 3, 2026, filed Mar 5, 2026, scored 38 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $2.9M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
COLL: COLLEGIUM PHARMACEUTICAL, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | COLLEGIUM PHARMACEUTICAL, INC | $2.0M 49,976 shares | -41% | +62% from low-20% from high | |
| 16Weak | COLLEGIUM PHARMACEUTICAL, INC | $848k 17,600 shares | -15% | +94% from low0% from high | |
| 20Weak | COLLEGIUM PHARMACEUTICAL, INC | $626k 16,389 shares | -14% | +55% from low-9% from high | |
| 7Weak | COLLEGIUM PHARMACEUTICAL, INC | $185k 4,861 shares | -4% | +53% from low-10% from high | |
| 28Weak | COLLEGIUM PHARMACEUTICAL, INC | $625k 20,808 shares | -17% | - | |
| 18Weak | COLLEGIUM PHARMACEUTICAL, INC | $68k 2,255 shares | -2% | - | |
| 32Weak | COLLEGIUM PHARMACEUTICAL, INC | $462k 15,387 shares | -11% | - | |
| 21Weak | COLLEGIUM PHARMACEUTICAL, INC | $169k 5,643 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 3, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | 49,976 0.16% of outstanding | $2.0M | Mar 3, 2026 | $848k |
| Dec 8, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 17,600 0.06% of outstanding | $848k | Dec 8, 2025 | none |
| Aug 18, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 16,389 0.05% of outstanding | $626k | Aug 18, 2025 | $185k |
| Aug 13, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 4,861 0.02% of outstanding | $185k | Aug 13, 2025 | none |
| Mar 21, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 18,881 0.06% of outstanding | $567k | Mar 21, 2025 | $756k |
| Mar 20, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 1,927 0.01% of outstanding | $58k | Mar 20, 2025 | $699k |
| Mar 14, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 2,255 0.01% of outstanding | $68k | Mar 14, 2025 | $631k |
| Mar 11, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 15,387 0.05% of outstanding | $462k | Mar 11, 2025 | $169k |
| Mar 7, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 2,348 0.01% of outstanding | $70k | Mar 7, 2025 | $99k |
| Mar 6, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 3,295 0.01% of outstanding | $99k | Mar 6, 2025 | none |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -46,417 | $40.36 | $1.9M | 75,329 | Mar 5, 2026 |
| Mar 3, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -3,559 | $40.99 | $146k | 71,770 | Mar 5, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +19,023 | $0.00 | $0 | 122,636 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +30,702 | $0.00 | $0 | 153,338 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -9,977 | $46.75 | $466k | 143,361 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -21,615 | $46.75 | $1.0M | 121,746 | Feb 12, 2026 |
| Dec 8, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Common Stock10b5-1 | +17,600 | $15.90 | $280k | 121,213 | Dec 10, 2025 |
| Dec 8, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -11,125 | $47.89 | $533k | 110,088 | Dec 10, 2025 |
| Dec 8, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -6,475 | $48.66 | $315k | 103,613 | Dec 10, 2025 |
| Dec 8, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -17,600 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Aug 18, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Common Stock10b5-1 | +16,389 | $21.34 | $350k | 120,002 | Aug 20, 2025 |
| Aug 18, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -16,389 | $38.21 | $626k | 103,613 | Aug 20, 2025 |
| Aug 18, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -16,389 | $0.00 | $0 | 0 | Aug 20, 2025 |
| Aug 13, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Common Stock10b5-1 | +4,861 | $21.34 | $104k | 108,474 | Aug 15, 2025 |
| Aug 13, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -4,861 | $38.03 | $185k | 103,613 | Aug 15, 2025 |
| Aug 13, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -4,861 | $0.00 | $0 | 16,389 | Aug 15, 2025 |
| Mar 20, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -1,927 | $30.00 | $58k | 122,494 | Mar 24, 2025 |
| Mar 21, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -18,881 | $30.03 | $567k | 103,613 | Mar 24, 2025 |
| Mar 14, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -2,255 | $30.00 | $68k | 124,421 | Mar 18, 2025 |
| Mar 6, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -15,387 | $30.00 | $462k | 126,676 | Mar 13, 2025 |
| Mar 6, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -3,295 | $30.00 | $99k | 144,411 | Mar 10, 2025 |
| Mar 7, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -2,348 | $30.00 | $70k | 142,063 | Mar 10, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +45,016 | $0.00 | $0 | 150,918 | Feb 12, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +26,411 | $0.00 | $0 | 177,329 | Feb 12, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -7,953 | $30.52 | $243k | 169,376 | Feb 12, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -21,670 | $30.52 | $661k | 147,706 | Feb 12, 2025 |
Questions about Scott Dreyer
Answered from the filings on this page, as of the latest one.
Is Scott Dreyer buying or selling?
In the last 12 months Scott Dreyer reported 0 open-market buys worth $0 and 2 open-market sells worth $2.9M on SEC Form 4; the latest was sold $2.0M of COLL on Mar 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Scott Dreyer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Scott Dreyer has 0.
Where does Scott Dreyer file Form 4?
Scott Dreyer has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC) as EVP & Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.